NCT00398411 · OUTCOME

Overall Survival

Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells · Source last updated 2015-06-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: follow up visit (at discharge from hospital up to a maximum of 28 days after transplantation)

Analysis population: intention to treat (ITT)

Groups in this outcome

Moxifloxacin

moxifloxacin 400 mg tablets once daily

Placebo

identical appearing placebo

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Moxifloxacin	34
Placebo	32

Reported measurements

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Moxifloxacin	34	Not reported	Not reported	Not reported	Not reported
Placebo	31	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
34
group Id
OG001
value
31

denoms

counts
group Id
OG000
value
34
group Id
OG001
value
32
units
Participants

groups

description
moxifloxacin 400 mg tablets once daily
id
OG000
title
Moxifloxacin
description
identical appearing placebo
id
OG001
title
Placebo

param Type

NUMBER

population Description

intention to treat (ITT)

reporting Status

POSTED

time Frame

follow up visit (at discharge from hospital up to a maximum of 28 days after transplantation)

title

Overall Survival

type

SECONDARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice